Interstitial Lung Diseases Clinical Trial
Official title:
Registration of Clinical Data and DNA/Serum of Patients With Interstitial Lung Diseases (ILD)
The cause of most interstitial lung diseases (ILDs) is still unknown. Further research, for example to determine predisposing genetic factors, is therefore needed. A database with relevant clinical data and DNA/serum samples of ILD patients could facilitate future research on the cause of ILDs.
Protocol title: 'Registration of clinical data and DNA of patients with Interstitial Lung
Disease (ILD)' Rationale: The etiopathogenesis of most Interstitial Lung Diseases (ILDs) is
still unknown. Further research, e.g. to determine predisposing genetic factors, is
therefore needed. A database with relevant clinical data and DNA/serum samples of ILD
patients could facilitate future research on the etiopathogenesis of ILDs.
Objective: Availability of relevant clinical data and DNA/serum samples of ILD patients in a
database. Those data can be used for future research.
Study design: A prospective observational study
Study population: Patients diagnosed with ILD attending the pulmonology department in
participating hospitals.
Intervention: a blood sample is taken from each patient. Furthermore, additional information
is collected from the medical file.
Main study parameters/endpoints: DNA and serum sample, demographic variables, medical
information, occupational history and hobbies.
Nature and extent of the burden and risks associated with participation, group relatedness:
two tubes of blood will be drawn from the patients. The risks of drawing blood from a vein
are minimal.
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05828953 -
Anlotinib Capsules in the Treatment for IPF/PF-ILDs
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT02951416 -
Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank
|
||
Recruiting |
NCT00470327 -
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
|
||
Completed |
NCT00512967 -
The Occurence of Inflammation and Oxidative Stress in Lung Diseases
|
N/A | |
Completed |
NCT02689102 -
Confocal Laser Endomicroscopy and Optical Coherence Tomography for Diagnosing ILD.
|
N/A | |
Completed |
NCT02796781 -
Autologous Lung Stem Cell Transplantation in Patients With Interstitial Lung Diseases
|
Phase 1/Phase 2 | |
Completed |
NCT00129701 -
Can we Reduce Hospital Attendance Without Compromising Care by the Use of Telephone Consultation
|
N/A | |
Recruiting |
NCT04855305 -
Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease
|
Phase 2 | |
Recruiting |
NCT01858259 -
Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis
|
N/A | |
Recruiting |
NCT06068647 -
Ultrasound and Respiratory Physiological Signals in Lung Diseases
|
N/A | |
Enrolling by invitation |
NCT05455437 -
Monitoring and Evaluation Study of Project ECHO for ILD
|
||
Recruiting |
NCT01211015 -
Endoplasmic Reticulum Stress in Chronic Respiratory Diseases
|
N/A | |
Recruiting |
NCT04370158 -
Interstitial Lung Diseases Cohort Study in China
|
||
Enrolling by invitation |
NCT05727852 -
Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases
|
||
Completed |
NCT02711657 -
Fibrocytes in Rheumatoid Arthritis, Asthma and Interstitial Lung-disease.
|
N/A | |
Completed |
NCT02763540 -
Pathological Comparisons of Surgical Open Lung Biopsies and Cryobiopsies in Non-IPF ILD
|
N/A | |
Recruiting |
NCT06036719 -
Interstitial Lung Disease: A Study From Infancy to Elderly Including Relatives
|
||
Completed |
NCT02549248 -
Nanoparticles Analysis in Lung and Bronchi During Various Pulmonary Interstitial Diseases and Relationships With Their Aetiology
|
N/A | |
Enrolling by invitation |
NCT02509364 -
Study of the Etiology and Immunological Pathogenesis in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF)
|
N/A | |
Completed |
NCT00741572 -
Individual Sensitivity for Interstitial Lung Diseases
|
N/A |